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Summary
Background Although eﬀ ective topical repellents provide personal protection against malaria, whether mass use of 
topical repellents in addition to long-lasting insecticidal nets can contribute to a further decline of malaria is not 
known, particularly in areas where outdoor transmission occurs. We aimed to assess the epidemiological eﬃ  cacy 
of a highly eﬀ ective topical repellent in addition to long-lasting insecticidal nets in reducing malaria prevalence in 
this setting.
Methods A cluster randomised controlled trial was done in the 117 most endemic villages in Ratanakiri province, 
Cambodia, to assess the eﬃ  cacy of topical repellents in addition to long-lasting insecticidal nets in controlling malaria 
in a low-endemic setting. We did a pre-trial assessment of village accessibility and excluded four villages because of 
their inaccessibility during the rainy season. Another 25 villages were grouped because of their proximity to each other, 
resulting in 98 study clusters (comprising either a single village or multiple neighbouring villages). Clusters were 
randomly assigned (1:1) to either a control (long-lasting insecticidal nets) or intervention (long-lasting insecticidal nets 
plus topical repellent) study group after a restricted randomisation. All clusters received one long-lasting insecticidal 
net per individual, whereas those in the intervention group also received safe and eﬀ ective topical repellents (picaridin 
KBR3023, SC Johnson, Racine, WI, USA), along with instruction and promotion of its daily use. Cross-sectional 
surveys of 65 randomly selected individuals per cluster were done at the beginning and end of the malaria transmission 
season in 2012 and 2013. The primary outcome was Plasmodium species-speciﬁ c prevalence in participants obtained by 
real-time PCR, assessed in the intention-to-treat population. Complete safety analysis data will be published seperately; 
any ad-hoc adverse events are reported here. This trial is registered with ClinicalTrials.gov, number NCT01663831.
Findings Of the 98 clusters that villages were split into, 49 were assigned to the control group and 49 were assigned to 
the intervention group. Despite having a successful distribution system, the daily use of repellents was suboptimum. 
No post-intervention diﬀ erences in PCR plasmodium prevalence were observed between study groups in 2012 (4·91% 
in the control group vs 4·86% in the intervention group; adjusted odds ratio [aOR] 1·01 [95% CI 0·60–1·70]; p=0·975) 
or in 2013 (2·96% in the control group vs 3·85% in the intervention group; aOR 1·31 [0·81–2·11]; p=0·266). Similar 
results were obtained according to Plasmodium species (1·33% of participants in the intervention group vs 1·10% in 
the intervention group were infected with Plasmodium falciparum; aOR 0·83 [0·44–1·56]; p=0·561; and 1·85% in the 
control group vs 2·67% in the intervention group were infected with Plasmodium vivax; aOR 1·51 [0·88–2·57]; 
p=0·133). 41 adverse event notiﬁ cations from nine villages were received, of which 33 were classiﬁ ed as adverse 
reactions (11 of these 33 were cases of repellent abuse through oral ingestion, either accidental or not). All participants 
with adverse reactions fully recovered and 17 were advised to permanently stop using the repellent.
Interpretation Mass distribution of highly eﬀ ective topical repellents in resource-suﬃ  cient conditions did not 
contribute to a further decline in malaria endemicity in a pre-elimination setting in the Greater Mekong subregion. 
Daily compliance and appropriate use of the repellents remains the main obstacle.
Funding Bill & Melinda Gates Foundation.
Copyright © The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license.
Introduction
During the past decade, the scaling up of long-lasting 
insecticidal nets and, to a lesser extent, indoor residual 
spraying has contributed to a worldwide decline in the 
malaria burden.1 These highly eﬀ ective vector control 
tools target mosquitoes resting or feeding indoors at 
night. Impregnated bednets inhibit blood feeding and 
induce a mass killing eﬀ ect on vector populations 
assuring community protection against malaria.2 
None theless, some malaria vectors show early and 
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outdoor biting behaviour,3 causing community pro-
tection to remain incomplete as a proportion of the 
vector popu lation is not exposed to the insecticides.3 
To tackle this remaining or residual transmission, 
additional vector control tools are required, particularly 
in settings where malaria control programmes move 
towards elimination.4
Topical repellents possess the potential to target residual 
transmission. Entomological evidence has shown that 
repellents provide personal protection against malaria.5,6 
However, the eﬃ  cacy of large-scale coverage of repellents 
on community protection against malaria remains 
unveriﬁ ed. Previous studies have assessed the eﬃ  cacy of 
topical repellents against malaria infection using 
individual randomised designs,7 household randomised 
trials,5,6,8,9 and several com munity-based studies.10–12 A 
meta-analysis13 concluded that topical repellents are 
ineﬀ ective in preventing malaria morbidity, with 
substantial diﬀ erences in study design among the studies 
included in the ﬁ nal analysis (nine for Plasmodium 
falciparum and seven for Plasmodium vivax). The main 
limitation of these studies lies in the diversion of vectors 
from individual or household repellent users to non-
users, spillover eﬀ ects because of geographical con-
tiguous com munities, or follow-up periods immediately 
after the onset of the intervention.14 A large-scale, cluster 
randomised trial attempting complete and continuous 
coverage of the vector control tool in the intervention 
group over two transmission seasons was expected to 
have a more uniform eﬀ ect on malaria transmission. 
Moreover, wide-scale use of repellents in the community 
(cluster) can induce a reduction of the malaria burden 
by reducing human–vector contact,15,16 the so-called, 
mass-eﬀ ect.
In the Greater Mekong subregion, a diverse community 
of malaria vectors is present, several of which are known 
to feed outdoors and before nightfall, compromising the 
eﬀ ectiveness of domicile vector control tools such as 
long-lasting insecticidal nets and indoor residual 
spraying.17 We hypothesised that the synergy between 
indoor night-time protection of a long-lasting insecticidal 
net and outdoor evening protection of a topical repellent 
would further reduce the malaria transmission intensity, 
by aﬀ ecting the vector population remaining outdoors. 
We aimed to assess the epidemiological eﬃ  cacy of a 
highly eﬀ ective topical repellent in addition to long-lasting 
insecticidal nets in the province of Ratanakiri, Cambodia, 
a region where vectors are known to show outdoor and 
early evening biting behaviour.18
Methods
Study design and participants
We did a cluster randomised controlled trial in the most 
endemic 117 of 240 villages in Ratanakiri province.19 
Average past incidence data (2010–11) were used to select 
the most endemic villages. Four villages were omitted 
Research in context
Evidence before this study
We searched PubMed and Web of Science, with no date or 
language restrictions, for studies on malaria vector control using 
topical repellents up to December, 2015, with the terms 
“anopheles”, “malaria”, “topical repellent”, “vector control”, 
“outdoor biting”, and combinations thereof. We found that 
highly eﬀ ective vector control measures such as impregnated 
bednets and indoor residual spraying contributed substantially 
to a worldwide decline in malaria morbidity and mortality. 
These control measures target mainly the indoor biting vector 
population. Persisting transmission because of early and 
outdoor mosquito biting behaviour hampered further reduction 
in malaria infections, particularly in low-endemic settings. 
Topical repellents provided personal protection against indoor 
and outdoor biting vectors. To what extent mass use of a topical 
repellent in addition to bednet usage can reduce malaria 
transmission at the community level remains unclear. A recent 
meta-analysis based on a small number of studies, but using 
diﬀ erent study designs, concluded that topical repellents provide 
individual protection against mosquitoes, but were unlikely to 
provide eﬀ ective protection against malaria.
Added value of this study
We present the results of a large cluster randomised trial 
designed to assess the eﬃ  cacy of mass use of topical repellent 
in addition to insecticide impregnated bednets at the 
community level. No post-intervention diﬀ erences for 
Plasmodium falciparum or Plasmodium vivax malaria between 
treatment groups was found. Daily compliance and 
appropriate use of the repellents, achieved under optimum 
trial conditions with suﬃ  cient resources to promote and 
distribute the repellent product, remain the main obstacles. 
Mass distribution of highly eﬀ ective topical repellents in 
addition to impregnated bednets did not contribute to a 
further decrease in malaria endemicity in a pre-elimination 
setting in Cambodia.
Implications of all the available evidence
Eﬀ ective topical repellents, properly applied, provide personal 
protection against mosquitoes, including malaria vectors. 
To what extent they can contribute to community-level 
protection against malaria infection remains unclear. Our study 
is unique in that it provides a randomised, large-scale, 
cluster-based design, which allows for the assessment of the 
eﬃ  cacy of a topical repellent at the community level. 
Mass distribution of a topical repellent does not contribute to a 
further decline in malaria infections at the community level in a 
low-endemic setting. Therefore, the search for innovative 
vector control strategies able to halt persisting outdoor malaria 
transmission, remains ongoing. 
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because of inaccessibility in the rainy season. Because of 
their proximity, another 25 villages were grouped into 
ten clusters. Hence, the study took place in 98 clusters, 
consisting of either a single village or a group of 
neighbouring villages. According to a 2012 population 
census, which was updated in 2013, the total population 
residing in the selected study villages was 48 838 individuals. 
The province is largely inhabited by Indigenous groups 
such as the Jarai, Kreung, and Tumpuon, as opposed to the 
Khmer in the rest of Cambodia. They generate revenue by 
subsistence slash-and-burn farming on plots located near 
or in the forest and less frequently on wet rice ﬁ elds. 
During the rainy season most of them leave the village and 
stay on their plot farm.20
The study was organised as a cluster randomised trial 
with two groups (ﬁ gure 1). All communities received 
a long-lasting insecticidal net (Olyset, Sumitomo 
Chemicals, Japan), with one net provided per person. 
Additionally, all households in the intervention group 
were provided with topical repellents (picaridin KBR3023, 
SC Johnson, Racine, WI, USA) during the malaria 
season (April–December) following a biweekly repellent 
distribution schedule.21 Children (aged ≤10 years) were 
provided with a 10% milky lotion formulation, and adults 
a 20% spray formulation. The content of the active 
ingredient (picaridin 10% or 20%) and relevant impurities 
were in agreement with the WHO speciﬁ cations. 
Entomological eﬃ  cacy of the topical repellent was high 
against indigenous primary and secondary malaria 
vectors (>95% protection for at least 5 h).22
The study protocol (available on request) was approved 
by the Institutional Review Board of the Institute of 
Tropical Medicine Antwerp (approval IRB/AB/ac/154), 
the Ethics Committee of the University of Antwerp 
(approval B300201112714), and the Cambodian National 
Ethics Committee on Health Research (approval 
265 NECHR). Village leaders provided written informed 
consent for the participation of their community in the 
trial. Individual written informed consent was obtained 
from all participants in the surveys. Parents provided 
consent for children younger than 10 years. All personal 
information was anonymised using reference numbers, 
and individual names were removed from the ﬁ nal 
database. Conﬁ dentiality agreements were signed by all 
participating research teams. A reproducible data 
analysis report in R markdown format including data 
and R code for the primary outcome will be made 
available in an online public repository. Secondary 
outcome measures are currently used by PhD students 
for further research and will be made available upon 
request.
Randomisation and masking
The 98 clusters were randomly assigned (1:1) to either 
receive long-lasting insecticidal nets (control) or long-
lasting insecticidal nets plus topical repellent (inter-
vention). Randomisation was constrained taking into 
account eight diﬀ erent restriction factors to ensure a 
spatially well balanced study design (ﬁ gure 2). Data from 
the pre-trial study19 were used to restrict randomisation 
by prevalence, participant response rate, and equity 
of clusters having zero prevalence. Additionally, past 
incidence (2010–11), population size, presence of 
Pre-trial Survey 1 Survey 2
Survey 3 Survey 4
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Pre-trial: 
6·34%
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Survey 1: 
4·04%
Survey 3: 
3·44%
Survey 3: 
3·37%
Survey 1: 
4·23%
Control arm: 
long-lasting insecticidal nets
49 clusters
49 clusters
Intervention arm: 
long-lasting insecticidal nets plus picaridin
Survey 2: 
4·91%
Survey 4: 
2·96%
Survey 2: 
4·86%
Survey 4: 
3·85%
January–February, 2012 April–May, 2012 October–November, 2012
March–April, 2013 October–November, 2013
+
 Figure 1: Design of the cluster randomised trial with two study groups. Grey boxes indicate the timing of the 
surveys during which the primary endpoint (PCR prevalence) was obtained
For the online public repository 
see https://zenodo.org/
record/55711
Control
Intervention
Ratanakiri province
Cambodia
Study clusters
0 40 km
Figure 2: Location of the communities allocated to treatment group by 
restricted randomisation in Ratanakiri province, Cambodia
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village malaria workers, minimum distance to the 
nearest community (>1500 m), and approximate 
geographical balance were used as balance criteria.23 
A restriction factor for the combined set of criteria was 
estimated from 1 000 000 randomly generated allocations 
and expressed as the proportion of acceptable allocations. 
Validity of the design of the restricted allocation process 
was investigated by verifying whether each pair of 
communities had the same probability of being allocated 
to the same treatment according to the balance criteria.23
Procedures
Five cross-sectional surveys were done over a 2 year 
period. The ﬁ rst survey, a pre-trial study, was done 
between Jan 31, 2012, and Feb 24, 2012, and used to 
obtain baseline information about malaria prevalence at 
the community level.19 Four additional cross-sectional 
surveys were done at the beginning and end of the 
transmission season (survey 1 between April 24, 2012, 
and May 16, 2012; survey 2 between Oct 22, 2012, and 
Nov 13, 2012; survey 3 between March 19, 2013, 
and April 10, 2013; and survey 4 between Oct 18, 2013, 
and Nov 9, 2013; ﬁ gure 1). Each survey consisted of a 
2-day sampling period per cluster to reach 65 participants 
randomly selected from the 2012 population census, to 
have a representative sample of the community (cluster). 
In case of a low response rate from the initially selected 
participants, an additional list of 15 randomly selected 
individuals was provided to the survey teams until they 
reached a minimum of 50 participants (ﬁ gure 3). 
This list of participants was provided 1 day in advance to 
the village chief, and many of the participants came to 
the village centre to collaborate. Others remained in 
their ﬁ elds or village houses. A team was sent out to 
search for them, some were found, others could not be 
located within the 2 day sampling window.
A capillary tube was used to collect blood samples of 
participating individuals from a ﬁ ngerprick. Blood was 
collected every day during each survey. 5 μL of blood was 
stored immediately in a labelled 96-well plate containing 
Whatman 3MM ﬁ lter paper. Additionally, two back up 
blood spots of 20 μL were stored on similar ﬁ lter paper. 
Baseline information, such as age, sex, and ethnicity of 
all the participants was collected in every survey alongside 
self-reported information about long-lasting insecticidal 
nets (survey 3 and 4) and repellent use (surveys 2, 3, and 
4). Health promotion campaigns were organised during 
the entire study period in all communities and in both 
study groups. Use of long-lasting insecticidal nets was 
promoted in the control and intervention group, whereas 
repellent use was promoted in the intervention group 
only. In the ﬁ rst year, the health promotion campaign 
methods used were oral information, leaﬂ ets, and 
posters, whereas in the second study year, visual media 
were additionally used to stimulate the use of net and 
repellent control measures.21
The repellent consumption rate was measured per 
family every 2 weeks during the repellent distribution by 
visual inspection of the leftover repellent divided into 
categories (eg, empty, half full, full).21 A proxy of daily 
compliance was estimated by self-reporting and 
observation. Participants were probed during surveys 2, 
3, and 4 with a standard questionnaire (eg, “did you 
use repellent yesterday/last week?”). Self-reported 
compliance to long-lasting insecticidal nets was queried 
in survey 3 and 4 with the question, “Did you sleep 
under a long-lasting insecticidal net last night?” Between 
survey three and four, a social science study was done to 
assess the acceptability and use of repellents in ten 
selected clusters.20
Outcomes
The primary endpoint was species-speciﬁ c malaria 
prevalence obtained through real-time PCR analysis 
using the method described by Canier and colleagues.24 
Prevalence was calculated for participants infected with 
any of the malaria species from the Plasmodium genus 
(Plasmodium spp), or separately, for participants 
infected with either P falciparum or P vivax. Plasmodium 
240 villages in Ratanakiri province
         149 997 individuals
117 most endemic villages assessed
for eligibility
113 villages (98 clusters) randomly assigned
10 929 households
48 838 individuals
49 clusters allocated to control group
56 villages
5287 households
23 787 individuals
3620 participants recruited for survey 1
2695 participants analysed for survey 1
3650 participants recruited for survey 1
2697 participants analysed for survey 1
3335 participants recruited for survey 2
2504 participants analysed for survey 2
          
3305 participants recruited for survey 2
2492 participants analysed for survey 2
         
3455 participants recruited for survey 3
2674 participants analysed for survey 3
            
3500 participants recruited for survey 3
2643 participants analysed for survey 3
3335 participants recruited for survey 4
2701 participants analysed for survey 4
            
3380 participants recruited for survey 4
2730 participants analysed for survey 4
          
49 clusters allocated to intervention group
57 villages
5642 households
25 051 individuals
4 excluded because of inaccessibility
Figure 3: Trial proﬁ le
The recruited participants not analysed were not present during the 2 day sampling period in each cluster.
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malariae and Plasmodium ovale were not reported 
separately because of low endemicity. Secondary 
outcomes were incidence and malaria exposure 
measured by serological markers. Incidence was 
measured through the passive case detection of the 
national health system (ie, health centre or hospital 
visits or village malaria workers)25 and a battery of 
21 malaria-speciﬁ c antigens was used as biomarkers for 
malaria exposure. A multiplex serological assay was 
done in a subset of 2000 random blood samples from 
survey 2 and 4.26 Antibody half-life was assessed with 
seroreversion rates27 and mixed linear regression 
models for repeated measure ments data (appendix p 2). 
This information was used as a reference to guide 
which malaria or vector antigens could provide insight 
into short-term immuno logical trends, hence allowing 
for comparison between treatment groups.28  Individuals 
who tested positive for PCR were visited, informed of 
their status, and treated free of charge within 24–48 h 
according to the Cambodian National Malaria 
Treatment guidelines. Complete safety analysis data 
will be published seperately; any ad-hoc adverse events 
are reported here.
Statistical analysis
The required sample size, taking into account a 30% 
individual dropout rate because of the foreseen 
diﬃ  culties in ﬁ nding participants within a 2 day window, 
was estimated at 3100 participants per treatment group, 
divided over 50 communities. The calculation was done 
to detect a 40% reduction in an expected PCR prevalence 
of 5% from the control group with a power of 80% and a 
between-cluster coeﬃ  cient of variation of k=0·5 using 
the formula described by Hayes and Moulton.23 
A retrospective power analysis was done with the same 
formula, but with a coeﬃ  cient of variation estimated 
from the data.
Comparison of primary and secondary outcomes 
between treatment groups was done with statistical 
methods, allowing for individual-level adjustments for 
age and sex, but also taking into account the clustered 
nature of the data. The PCR prevalence between the 
study groups was compared with a generalised 
estimation equation with an exchangeable correlation 
structure to account for the cluster-based design. For the 
intention-to-treat analysis (including all participants 
present for the respective surveys), data were examined 
per survey and adjusted for age and sex as speciﬁ ed a 
priori in the statistical analysis plan. The per-protocol 
analysis (including only the participants reporting to 
have used their net the day before [control group] or have 
used their bednet and applied repellent [intervention 
group] the day before present for the survey) was done in 
a subset of participants from the ﬁ nal survey (survey 4). 
Unadjusted and adjusted analyses for age and sex 
were done on the subset of data. Incidence per 
1000 person-months was calculated as the episodes per 
person per month at risk. Comparison of treatment 
groups for secondary outcomes was done with linear 
mixed models, taking into account the clustered nature 
of the study design and the appropriate error distribution; 
Poisson was selected for analysis of the incidence data 
and Gaussian was used to calculate the log-trans formed 
median ﬂ uorescent intensity of the serological markers. 
Averages of duplicated serological measures were 
obtained after outliers had been removed, according to 
the algorithm described by Eo and colleagues.29
All information was entered in an Access database 
with preprogrammed forms to minimise data entry 
errors by two independent data entry clerks. Standard 
double data checks were made and mismatches were 
corrected based on hard copies. Each individual was 
anonymised via a ten digit code and the PCR results 
were digitally merged with the survey data based on this 
unique code. The study was monitored by a data safety 
and management  board. All statistical analyses were 
done with software package R version 3.1.3. Literate 
programming techniques and markup language were 
used to ensure maximum reproducibility.30 This trial is 
registered with ClinicalTrials.gov, number NCT01663831.
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. The corresponding authors had full access to 
all the data in the study and had ﬁ nal responsibility for 
the decision to submit for publication.
See Online for appendix
Control (n=2695) Intervention (n=2697)
Age (years) 18 (9–32) 19 (8–33)
Female 1408 (52%) 1352 (50%)
Male 1285 (48%) 1345 (50%)
Risk behaviour
Plot hut 990 (37%) 1235 (46%)
Forest 244 (9%) 412 (15%)
Ethnic origin
Jarai 769 (29%) 679 (25%)
Tumpuon 682 (25%) 713 (27%)
Kreung 408 (15%) 672 (25%)
Prov 230 (9%) 188 (7%)
Other 599 (22%) 426 (16%)
Infection status
Plasmodium spp 114 (4·23%) 109 (4·04%)
Plasmodium 
falciparum
54 (2·00%) 44 (1·63%)
Plasmodium vivax 69 (2·56%) 85 (3·15%)
Data are median (IQR) or n (%). The number of participants excluded missing 
information for the characteristic of interest. Blood samples were collected in 
2695 participants in the control group and 2697 in the intervention group. Plot hut 
and forest refer to the overnight locations of participants.19,20
Table 1: Baseline characteristics of participants and PCR diagnostics per 
treatment group in survey 1 
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Results
During the malaria season of 2012, 71 726 bottles of 
100 mL repellent were distributed, averaging 
2·9 bottles per person per year. Intensiﬁ cation of 
promotional and organisational eﬀ orts in the second 
study year (2013) resulted in increased distributor–
family contact rates, leading to the distribution of 
223 510 bottles in 2013 and averaging 8·9 bottles per 
person per year.20 After the restricted randomisation, 
both baseline prevalence and charac teristics were 
found to be well balanced between the study groups 
(tables 1 and 2; ﬁ gures 1 and 2). The combined 
restriction factor was estimated to be 99·13% (95% CI 
99·11–99·15), whereby a total of 2·215 × 10²⁶ acceptable 
allocations remained.
PCR prevalence of malaria in the respective surveys 
was 4·23% (survey 1), 4·91% (survey 2), 3·37% (survey 3), 
and 2·96% (survey 4) in the control group and 4·04% 
(survey 1), 4·86% (survey 2), 3·44% (survey 3), and 
3·85% (survey 4) in the intervention group. Self-reported 
use of long-lasting insecticidal nets was over 90% and 
equal among study groups, taking into account the 
cluster eﬀ ect (survey 3: χ²=0·84, p=0·36; survey 4: 
χ²=1·81, p=0·18). After repellent distribution rounds in 
survey 2 and survey 4, 72% of participants in the 
intervention group and 69% of participants in the control 
group reported using the repellent the day before they 
participated. In the control group, where no repellent 
distribution took place, these ﬁ gures drop to 0·36% for 
survey 2 and 0·19% for survey 4.
The primary outcome measure of malaria prevalence 
did not diﬀ er between control and intervention groups 
in any of the follow-up surveys taking into account the 
cluster eﬀ ect (table 2). Repeating the analysis adjusted 
for age and sex did not alter the results. Secondary 
outcome measures conﬁ rmed the statistical results of 
the primary outcome. Annual incidence rates for all 
Plasmodium species combined, or separately for con-
ﬁ rmed P falciparum or P vivax cases did not diﬀ er 
between treatment groups, neither in 2012 nor in 2013 
(table 3). The median ﬂ uorescent intensity of the sero-
logical markers for P falciparum, P vivax, and P malariae 
did not diﬀ er between treatment groups (appendix p 1).
4416 (81%) of 5431 individuals were selected for the 
per-protocol analysis. In the control group, 2570 (95%) 
of 2701 participants reported to sleep under their 
bednets. In the intervention group, 1846 (68%) of 2730 
participants reported to both apply their topical 
Species Control Intervention IRR (95% CI) p value
2012 Plasmodium spp 99·76 
(2331/23 366)
87·55 
(2176/24 854)
0·920 (0·652–1·298) 0·636
2012 Plasmodium 
falciparum
43·57 
(1018/23 366)
38·99 (969/24 854) 0·887 (0·885–0·890) 0·730
2012 Plasmodium 
vivax
31·88 
(745/23 366)
28·20 (701/24 854) 0·885 (0·566–1·384) 0·594
2013 Plasmodium spp 51·16 
(1217/23 787)
45·79 (1147/25 051) 0·943 (0·642–1·385) 0·766
2013 P falciparum 21·82 
(519/23 787)
17·96 (450/25 051) 0·656 (0·316–1·360) 0·256
2013 P vivax 15·26 
(363/23 787)
16·69 (418/25 051) 0·982 (0·627–1·535) 0·934
Data are incidence (episodes of malaria/total person-months at risk), unless otherwise speciﬁ ed. IRR=incidence rate ratio.
Table 3: Incidence (per 1000 person-years) of symptomatic malaria cases as reported by the health 
system in the control group versus the intervention group
Control Intervention OR (95% CI) p value aOR (95% CI) p value
Survey 1
Plasmodium spp 114/2695 (4·23%) 109/2697 (4·04%) 0·961 (0·574–1·608) 0·878 1·052 (0·625–1·770) 0·849
Plasmodium 
falciparum
54/2695 (2·00%) 44/2697 (1·63%) 0·807 (0·448–1·451) 0·473 0·811 (0·445–1·478) 0·493
Plasmodium vivax 69/2695 (2·56%) 85/2697 (3·15%) 1·240 (0·719–2·139) 0·440 1·372 (0·803–2·345) 0·248
Survey 2
Plasmodium spp 123/2504 (4·91%) 121/2492 (4·86%) 0·987 (0·591–1·646) 0·959 1·008 (0·598–1·702) 0·975
P falciparum 49/2504 (1·96%) 63/2492 (2·53%) 1·308 (0·722–2·370) 0·376 1·316 (0·727–2·384) 0·364
P vivax 86/2504 (3·43%) 63/2492 (2·53%) 0·724 (0·416–1·259) 0·252 0·744 (0·415–1·333) 0·320
Survey 3
Plasmodium spp 90/2674 (3·37%) 91/2643 (3·44%) 1·040 (0·613–1·764) 0·884 1·087 (0·643–1·838) 0·755
P falciparum 33/2674 (1·23%) 36/2643 (1·36%) 1·130 (0·545–2·341) 0·743 1·179 (0·560–2·483) 0·664
P vivax 71/2674 (2·66%) 58/2643 (2·19%) 0·822 (0·488–1·386) 0·462 0·842 (0·497–1·426) 0·523
Survey 4
Plasmodium spp 80/2701 (2·96%) 105/2730 (3·85%) 1·296 (0·805–2·088) 0·286 1·311 (0·814–2·111) 0·266
P falciparum 36/2701 (1·33%) 30/2730 (1·10%) 0·814 (0·433–1·529) 0·523 0·829 (0·440–1·561) 0·561
P vivax 50/2701 (1·85%) 73/2730 (2·67%) 1·448 (0·846–2·478) 0·177 1·505 (0·883–2·566) 0·133
Data are n/N (%), unless otherwise speciﬁ ed. No signiﬁ cant diﬀ erences between control and intervention group were noted. OR=odds ratio. aOR=adjusted odds ratio.
Table 2: Real-time PCR prevalence results of all surveys in 2012 and 2013 for the intention-to-treat analysis
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repellents and sleep under their bednets the day before 
the last survey. No additional protective eﬀ ect was 
shown comparing the prevalence endpoints between 
the control and intervention group using the 
individual-level unadjusted and age-adjusted and sex-
adjusted analysis taking into account the cluster eﬀ ect 
(table 4).
833 participants were recorded as being infected with 
plasmodium of any species during the four surveys. 
Of these, 814 (98%) took treatment in front of the village 
malaria worker or provincial health department ﬁ eld 
staﬀ . Standard 3-day treatment with dihydroartemisinin-
piperaquine was provided to 748 (92%) infected 
participants, and 66 (8%) received artesunate-meﬂ oquine. 
Six pregnant women were referred to a health centre for 
further treatment.
Over the 2-year study period, 41 ad-hoc adverse event 
notiﬁ cations from nine villages were received. After the 
visit by the project medical doctor, 33 events were 
classiﬁ ed as adverse reactions, of which 11 were cases of 
repellent abuse through oral ingestion, either accidental 
or not. All participants with adverse reactions fully 
recovered and 17 of them were advised to permanently 
stop using the repellent. Additionally, a monitoring 
system at the family level was put in place to document 
perceived side-eﬀ ects.
Discussion
This cluster randomised trial, designed to detect 
population-level rather than individual eﬀ ects, did not 
show a reduction in malaria infection and disease in the 
intervention group. When compared with earlier cluster-
based intervention studies of topical repellents, this trial 
was scaled up by a factor of six, incorporating 49 clusters 
(communities) in each treatment group. All existing 
homesteads had continuous access to repellents and 
received long-lasting insecticidal nets. Given the large 
number of randomised clusters, any confounder that 
might aﬀ ect the measured outcomes was likely to be 
balanced between the two study groups, including the 
proportion of P vivax relapses, which are not aﬀ ected by 
vector control tools.
The study, which was done in a multidisciplinary 
setting, aimed to cover the epidemiological, entomo-
logical, and anthropological aspects of the trial, 
obtained three epidemiological endpoints: PCR 
prevalence, incidence, and malaria exposure measured 
by serological markers. Similar trends were observed 
in these three outcomes and no indication for a sup-
plementary protective eﬀ ect provided by mass use of 
topical repellents in addition to long-lasting insecticidal 
nets on malaria prevalence was found. These results 
are in line with a recent meta-analysis13 of household 
and small community randomised trials in which 
repellents were found unlikely to provide eﬀ ective 
protection against malaria. As previously reported,22 
the picaridin repellent product showed high individual 
protective eﬃ  cacy against bites from malaria vectors in 
the same area. However, in the 4788 anopheles 
mosquitoes that were collected in two control and 
two intervention villages during 2240 human landing 
collection nights by untreated collectors, no 
P falciparum and P vivax sporozoite carriers were 
detected by circum sporozoite protein enzyme-linked 
immuno sorbent assay (Durnez L, Institute of Tropical 
Medicine, Belgium, unpublished). Additionally, a social 
science work package investigated the sociocultural 
factors aﬀ ecting the eﬀ ectiveness of the intervention, 
including accessibility, acceptance, and actual daily 
skin application of the repellent.20,21
Three limiting factors of the present study design 
might have hindered the rejection of the null hypothesis 
of there being no diﬀ erence between treatment groups. 
First, the study was powered to detect a 40% diﬀ erence 
in an expected PCR prevalence of 5% from the control 
group with a cluster coeﬃ  cient of variation k=0·5 and a 
power of 80%. A retrospective power analysis, based on 
the observed data (ie, higher estimated k of 1 and lower 
ﬁ nal prevalence of 3% in the control group), suggested 
that with a given power of 80%, the actual study design 
could only detect diﬀ erences larger than 46% between 
study groups. Second, each individual that was found 
positive for malaria was treated according to the national 
guidelines within 24–48 h on detection by PCR, because 
it was considered unethical not to provide immediate 
treatment to the participants who tested positive for 
malaria. Given that this treatment was provided to 
participants randomly selected for the cross-sectional 
surveys only and equally in both study groups, it was 
expected to have a negligible eﬀ ect on the study outcome. 
Lastly, although self-reported repellent consumption was 
high (72% in survey 2 and 69% in survey 4 in the 
intervention group), and contamination of the control 
clusters was low (0·36% in survey 2 and 0·19% in survey 
4 in the control group), repellent use might not have 
been optimum. An independent anthropological study 
parallel to the trial, using both quantitative and 
qualitative methods,20 found that 59% of the respondents 
of a cross-sectional survey done in all intervention 
clusters reported to use the repellent 7 days a week. 
Observational studies done in a small selection of 
ten clusters in the intervention group resulted in 
Control 
(n=2570)
Intervention 
(n=1846)
OR (95% CI) p value aOR (95% CI) p value
Plasmodium 
spp
2·68% 4·01% 1·454 (0·847–2·497) 0·175 1·499 (0·870–2·583) 0·145
Plasmodium 
falciparum
1·17% 0·98% 0·815 (0·407–1·633) 0·564 0·820 (0·407–1·651) 0·579
Plasmodium 
vivax
1·63% 2·87% 1·712 (0·922–3·181) 0·089 1·790 (0·966–3·318) 0·064
Unadjusted OR and aOR statistics with 95% CI were reported. OR=odds ratio. aOR=adjusted odds ratio.
Table 4: Results of the per-protocol analysis of the real-time PCR prevalence for survey four
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without the picaridin repellent formulations provided by the production 
company, SC Johnson, Racine, WI, USA, free of charge. This study was 
funded by the Bill & Melinda Gates Foundation Global Health Grant 
OPP1032354.
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evening skin application rates between 6% and 15%.20 
Considering the diﬃ  culty in obtaining an unbiased 
estimate of actual repellent skin application at the 
community level, our best estimate lies between what 
was self-reported (70%) and what was observed in a 
small number of clusters (15%). According to the 
qualitative component of the same observational study, 
repellent use was highly variable and alternative uses 
other than skin applications were common. Although 
these results indicate that daily repellent use was 
suboptimum, it was consistently higher in men during 
forest-related activities. This was partly because of 
perceived insect nuisance while performing activities 
such as slash-and-burn farming or hunting in the forest. 
Although repellent use improved over the course of the 
intervention as a result of intensive and continuous 
promotion of appropriate use of the repellent in the 
intervention clusters, it remained suboptimum and 
highly variable.
This cluster randomised trial, designed to assess the 
epidemiological eﬃ  cacy of community-wide use of 
topical repellents in addition to long-lasting insecticidal 
nets, did not show a reduction in malaria infection and 
disease in the intervention group. Although individual 
protective eﬃ  cacy of repellents against malaria vectors 
remains guaranteed, the results of this cluster-based 
trial support the conclusion that community-wide 
distribution of highly eﬀ ective topical repellents 
might not contribute to a further decrease of malaria 
endemicity in a pre-elimination setting. Daily 
compliance and appropriate use of the repellents, 
achieved under optimum trial conditions with suﬃ  cient 
resources to promote and distribute the repellent 
product, remain the main obstacles. We conclude that 
mass distribution of topical repellents in addition to 
long-lasting insecticidal nets has no added public health 
value in preventing malaria in low endemic countries 
from the Greater Mekong sub-region.
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